| Name | Title | Contact Details |
|---|
Authentic® is a community of Fractional CMOs who help growing businesses Overcome Random Acts of Marketing® and confidently take the next right step to build revenue. Our unique approach combines Marketers + Methodology + Mindshare to build strong, strategic, sales-aligned marketing teams and programs.
Polestar Solutions & Services is a global AI and analytics company focused on enterprise transformation through data-driven solutions. Founded by experienced technocrats, the company operates in the U.S. and India, with offices in cities like Dallas, Noida, and Mumbai. With over 600 employees, Polestar is projected to grow by 60% globally in the coming year. The company specializes in AI-powered analytics, serving industries such as consumer packaged goods, retail, manufacturing, and pharmaceuticals. Polestar offers a range of services, including generative AI, data engineering, and advanced analytics platforms. It develops tailored solutions for revenue growth management, supply chain optimization, and customer analytics. Polestar is recognized as a Great Place to Work and has received multiple awards for its growth and excellence in AI and analytics services. Its mission is to empower businesses through intelligent, data-driven transformation.
Mymcpl is a Missouri-based nonprofit organization that provides notary, remote printing, and passport services for individuals.
The impact of disasters—natural or otherwise—can leave even the most robust entities vulnerable, causing uncertainty over their future. This constant threat magnifies stress, strains resources, and hampers growth, making resilience more crucial than ever. At Tidal Basin Group, we tackle these challenges head-on. As architects of resilience, we transform vulnerability into strength through innovative thinking and integrated solutions in program management, technology and emergency consulting. We listen, consider diverse perspectives, and equip you with the tools to redefine resilience. Our mission is to empower organizations and communities to rebound from challenges, and create a future where resilience is the backbone of every strategy—helping everyone to Be stronger than before®.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.